Opinion

... in response to Caffeine Pharmacology
  1. Caffeine and liver disease
    Luci Baldwin Luci Baldwin Australia says:
    January 22, 2020 at 1:53 AM

    The article needs to be changed. It states caffeine should be avoided in those with liver disease, however a 2016 systematic review and meta-analysis of 20,064 subjects showed that Although "caffeine intake is not associated with the prevalence or hepatic fibrosis of Non Alcoholic Fatty Liver Disease (NAFLD)" and "regular coffee caffeine consumption may significantly reduce hepatic fibrosis in patients with NAFLD". This means that caffeine may help prevent liver scarring in fatty liver disease, and does no harm - it should not be avoided in those with NAFLD/NASH!
    https://www.ncbi.nlm.nih.gov/pubmed/26770272

    Reply
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback